CaPSURE™

CEASAR

CEASAR stands for Comparative Effectiveness Analysis of Surgery and Radiation. The ongoing goal of CEASAR is to help learn more about what prostate cancer treatments work best, for which patients, in whose hands.

There are currently about 3,600 men with a prostate cancer diagnosis participating in CEASAR. Three rounds of surveys have been completed, with the first carried out in the spring of 2010. We are currently in the process of conducting our fourth survey with the same group of men in our study. This survey, our Three Year Follow-up, will occur throughout the summer of 2014. Click here and scroll to the bottom of the listing for the CEASAR papers.

In addition to continuing to collect more data through additional surveys, we are also now working to analyze the data from earlier surveys and to present our findings through research papers and presentations. Links to published papers can be found here.

Learn more about CEASAR here.

Newsletters

CaPSURE Chronicles 2017

CaPSURE Chronicles 2015

CEASAR Newsletter 2014

CaPSURE Chronicles 2013

CaPSURE Chronicles 2012

CaPSURE Chronicles 2011

CaPSURE Chronicles 2010

CaPSURE Chronicles 2009

CaPSURE: UCSF Cancer of the Prostate Strategic Urologic Research Endeavor

CaPSURE™ is a longitudinal, observational study of approximately 15,000 men with all stages of biopsy-proven prostate cancer. Patients have enrolled at 43 community urology practices, academic medical centers, and VA hospitals throughout the United States since 1995.

Physicians provide clinical data on their patients who have consented to be in the study:

• methods of screening
• PSA values at diagnosis and at every patient visit
• diagnostic and pathologic Gleason grade and stage
• surgical pathology
• primary, neoadjuvant, adjuvant, and salvage treatments

Patients contribute data before and at regular intervals after treatment:

• urinary, bowel, and sexual function
• general health
• comorbid conditions and medications
• lifestyle modification needed after diagnosis or treatment of prostate cancer
• satisfaction with medical care

CaPSURE™ research findings have expanded knowledge of prostate cancer risk prediction, diagnostic trends, treatment patterns, outcomes and quality of life. CaPSURE™ investigators have published more than 200 articles in peer-reviewed journals and presented hundreds of papers at professional conferences. Fellows, residents, and medical students, both at UCSF and at outside institutions, have authored many of the publications under the direction of senior investigators. The experience gained by these junior investigators has helped to shape and accomplish career goals.

If your urology practice is interested in becoming a core research CaPSURE™ site, please contact Jeanette Broering, PhD, MPH, RN Director of Data Procurement and Quality Assurance.

The CaPSURE™ study is funded and coordinated by the UCSF Department of Urology.
__________